Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 4.16 Billion JPY | 8247.74% |
| 2023 | 49.94 Million JPY | -0.92% |
| 2022 | 50.4 Million JPY | -1.12% |
| 2021 | 50.97 Million JPY | 3.68% |
| 2020 | 49.16 Million JPY | 24.17% |
| 2019 | 39.59 Million JPY | -19.51% |
| 2018 | 49.19 Million JPY | -25.13% |
| 2017 | 65.7 Million JPY | -15.62% |
| 2016 | 77.87 Million JPY | -99.08% |
| 2015 | 8.5 Billion JPY | -2.77% |
| 2014 | 8.74 Billion JPY | 7.81% |
| 2013 | 8.11 Billion JPY | 4.68% |
| 2012 | 7.75 Billion JPY | -9.89% |
| 2011 | 8.6 Billion JPY | 7.86% |
| 2010 | 7.97 Billion JPY | 6.31% |
| 2009 | 7.5 Billion JPY | 3.72% |
| 2008 | 7.23 Billion JPY | 19.38% |
| 2007 | 6.05 Billion JPY | -2.3% |
| 2006 | 6.2 Billion JPY | 8.21% |
| 2005 | 5.73 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 682 Million JPY | 8561.8% |
| 2024 FY | 4.16 Billion JPY | 8247.74% |
| 2024 Q1 | 9.02 Million JPY | -23.66% |
| 2024 Q2 | 7.18 Million JPY | -20.46% |
| 2024 Q3 | 7.87 Million JPY | 9.65% |
| 2023 Q4 | 11.82 Million JPY | -17.41% |
| 2023 Q1 | 13.68 Million JPY | 24.85% |
| 2023 FY | 49.94 Million JPY | -0.92% |
| 2023 Q3 | 14.31 Million JPY | 56.1% |
| 2023 Q2 | 9.17 Million JPY | -32.96% |
| 2022 Q4 | 10.95 Million JPY | -30.45% |
| 2022 Q3 | 15.75 Million JPY | 17.31% |
| 2022 FY | 50.4 Million JPY | -1.12% |
| 2022 Q1 | 13.45 Million JPY | -98.8% |
| 2022 Q2 | 13.43 Million JPY | -0.15% |
| 2021 Q2 | 1.52 Billion JPY | 33.68% |
| 2021 Q1 | 1.14 Billion JPY | -4.99% |
| 2021 Q3 | 1.83 Billion JPY | 20.22% |
| 2021 FY | 50.97 Million JPY | 3.68% |
| 2021 Q4 | 1.12 Billion JPY | -38.81% |
| 2020 Q3 | 1.5 Billion JPY | 19.59% |
| 2020 FY | 49.16 Million JPY | 24.17% |
| 2020 Q1 | 1.33 Billion JPY | 191.48% |
| 2020 Q4 | 1.2 Billion JPY | -20.23% |
| 2020 Q2 | 1.26 Billion JPY | -5.54% |
| 2019 FY | 39.59 Million JPY | -19.51% |
| 2019 Q1 | 1.24 Billion JPY | 21.17% |
| 2019 Q2 | 1.19 Billion JPY | -4.49% |
| 2019 Q3 | 1.48 Billion JPY | 24.5% |
| 2019 Q4 | 458 Million JPY | -69.14% |
| 2018 Q4 | 1.03 Billion JPY | -27.16% |
| 2018 Q3 | 1.41 Billion JPY | 7.53% |
| 2018 Q2 | 1.31 Billion JPY | -13.14% |
| 2018 Q1 | 1.51 Billion JPY | 9.08% |
| 2018 FY | 49.19 Million JPY | -25.13% |
| 2017 FY | 65.7 Million JPY | -15.62% |
| 2017 Q2 | 2 Billion JPY | -3.7% |
| 2017 Q1 | 2.08 Billion JPY | -6.3% |
| 2017 Q3 | 1.96 Billion JPY | -1.99% |
| 2017 Q4 | 1.38 Billion JPY | -29.4% |
| 2016 Q2 | 2.23 Billion JPY | 4.15% |
| 2016 FY | 77.87 Million JPY | -99.08% |
| 2016 Q3 | 2.17 Billion JPY | -2.59% |
| 2016 Q4 | 2.22 Billion JPY | 2.07% |
| 2016 Q1 | 2.14 Billion JPY | 6.5% |
| 2015 Q2 | 2.06 Billion JPY | 3.04% |
| 2015 Q1 | 2 Billion JPY | 8.08% |
| 2015 Q3 | 2.41 Billion JPY | 16.73% |
| 2015 FY | 8.5 Billion JPY | -2.77% |
| 2015 Q4 | 2.01 Billion JPY | -16.49% |
| 2014 Q4 | 1.85 Billion JPY | -27.74% |
| 2014 FY | 8.74 Billion JPY | 7.81% |
| 2014 Q3 | 2.57 Billion JPY | 15.71% |
| 2014 Q2 | 2.22 Billion JPY | 5.81% |
| 2014 Q1 | 2.09 Billion JPY | 30.53% |
| 2013 FY | 8.11 Billion JPY | 4.68% |
| 2013 Q3 | 2.46 Billion JPY | 21.8% |
| 2013 Q4 | 1.6 Billion JPY | -34.74% |
| 2013 Q1 | 2.01 Billion JPY | 26.92% |
| 2013 Q2 | 2.02 Billion JPY | 0.25% |
| 2012 Q3 | 2.16 Billion JPY | 19.21% |
| 2012 FY | 7.75 Billion JPY | -9.89% |
| 2012 Q1 | 2.18 Billion JPY | 16.2% |
| 2012 Q4 | 1.59 Billion JPY | -26.39% |
| 2012 Q2 | 1.81 Billion JPY | -17.18% |
| 2011 Q2 | 2.13 Billion JPY | -1.57% |
| 2011 Q3 | 2.42 Billion JPY | 13.76% |
| 2011 FY | 8.6 Billion JPY | 7.86% |
| 2011 Q1 | 2.16 Billion JPY | 24.87% |
| 2011 Q4 | 1.88 Billion JPY | -22.29% |
| 2010 Q1 | 1.98 Billion JPY | 12.64% |
| 2010 Q3 | 2.22 Billion JPY | 9.19% |
| 2010 Q2 | 2.03 Billion JPY | 2.57% |
| 2010 FY | 7.97 Billion JPY | 6.31% |
| 2010 Q4 | 1.73 Billion JPY | -22.01% |
| 2009 Q2 | 2.01 Billion JPY | 0.0% |
| 2009 FY | 7.5 Billion JPY | 3.72% |
| 2009 Q3 | 1.97 Billion JPY | -2.04% |
| 2009 Q4 | 1.76 Billion JPY | -10.68% |
| 2008 FY | 7.23 Billion JPY | 19.38% |
| 2007 FY | 6.05 Billion JPY | -2.3% |
| 2006 FY | 6.2 Billion JPY | 8.21% |
| 2005 FY | 5.73 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -357993.831% |
| Ansell Limited | 129.3 Million USD | -3124.285% |
| Ansell Limited | 129.3 Million USD | -3124.285% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -13288.704% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 261364.485% |
| Psykey, Inc. | -797.5 Thousand USD | 522855.999% |
| ConvaTec Group Plc | 262.7 Million USD | -1486.981% |
| ConvaTec Group Plc | 262.7 Million USD | -1486.981% |
| Encision Inc. | -640.78 Thousand USD | 650710.269% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 2939949.094% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 3792513.354% |
| Innovative MedTech Inc. | -4.27 Million USD | 97641.551% |
| LifePoint, Inc. | -7.49 Million USD | 55722.057% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 64436.42% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -1263233.333% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 3392564.806% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 892288.376% |
| SmileDirectClub, Inc. | -241.15 Million USD | 1828.756% |
| Sector 10, Inc. | -39.84 Thousand USD | 10463406.897% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -1204.415% |
| SheerVision, Inc. | 155.72 Thousand USD | -2677038.05% |
| United Health Products, Inc. | -2.42 Million USD | 171908.489% |
| Vasamed, Inc. | 4.74 Million USD | -87810.892% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 181823.791% |
| Yubo International Biotech Limited | -1.2 Million USD | 346011.089% |